Selected Grants
B Cell-Fibroblast Crosstalk Promotes Chronic GVHD of the Lung
ResearchAdvisor · Awarded by National Institute of Allergy and Infectious Diseases · 2024 - 2026Immunogenicity and risk of autoimmune cross-reactivity of COVID-19 mRNA vaccines in SLE - RRF Investigator Award
ResearchMentor · Awarded by Rheumatology Research Foundation · 2022 - 2026Combining a CD40L-Binding Protein (VIB4920) with a TNF alpha Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis
Clinical TrialPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2022 - 2026ITN Network Deputy Director
ResearchPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2021 - 2026CD40L-CD40 Pathway (VIB4920) In Rheumatoid Arthritis (Protocol Chair)
ResearchPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2019 - 2026A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VIB4920 IN SUBJECTS WITH SJOGREN'S SYNDROME (SS)
Clinical TrialPrincipal Investigator · Awarded by Viela Bio, Inc. · 2020 - 2025Pegloticase in Uncontrolled Gout who have undergone Kidney Transplant
Clinical TrialPrincipal Investigator · Awarded by Horizon Therapeutics Ireland DAC · 2019 - 2025Subaward Agreement - Benaroya to Duke - ITN Network Deputy Director of Clinical Affairs
ResearchPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2020 - 2021Immunological biomarker studies in myasthenia gravis
Clinical TrialAdvisor · Awarded by National Institutes of Health · 2014 - 2020Subaward Agreement - Benaroya to Duke - Immune Tolerance Network
ResearchPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2011 - 2020BMS-IM101-603
Clinical TrialPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2017 - 2019Training Program in Inflammatory and Immunological Diseases
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1980 - 2017Supplement from NIAID for Remaining ACE Invoices
Clinical TrialPrincipal Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2013 - 2017Mechanisms of B Cell Responses in Autoimmune Disease
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2003 - 2017A Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3200327 in Subjects with Active Sjögren¿s Syndrome
Clinical TrialPrincipal Investigator · Awarded by Lilly USA, LLC · 2016 - 2017Mechanisms of Insulin Resistance in Rheumatoid Arthritis
ResearchCo-Mentor · Awarded by National Institutes of Health · 2008 - 2015Scleroderma Cyclophosphamide or Transplantation (SCOT) Trial-Option 2
ResearchAdvisor · Awarded by National Institutes of Health · 2012 - 2013Mechanisms of Insulin Resistance in Rheumatoid Arthritis
ResearchCo-Mentor · Awarded by National Institutes of Health · 2008 - 2013Scleroderma Cyclophosphamide or Transplantation (SCOT) Trial
ResearchAdvisor · Awarded by National Institutes of Health · 2011 - 2012National Collaborative Study of Stem Cell Transplantation for Autoimmune Disease
ResearchAdvisor · Awarded by National Institutes of Health · 2011 - 2011Abatacept Vs TNF Blockade in Early Rheumatoid Arthritis: Planning for a Randomized, Double-Blind, Placebo-Controlled Trial
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2007 - 2009Human TNFa-Induced Pre-B Cell Bone Marrow Emigrants
ResearchSignificant Contributor · Awarded by National Institutes of Health · 2006 - 2009Mentored Clinical Research Scholar Program
ResearchAdvisor · Awarded by National Institutes of Health · 2002 - 2006General Clinical Research Center
ResearchCore Lab Dir · Awarded by National Institutes of Health · 1998 - 2006Novel Therapeutic Targets in Rheumatoid Arthritis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1999 - 2004same
ResearchAdministrative Assistant · Awarded by National Institutes of Health · 1987 - 2001The Carolina Lupus Research Study
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1997 - 1999Specialized Center Of Research In Rheumatoid Arthritis
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1987 - 1999General Clinical Research Center (Cru)
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1975 - 1998Intravenous Doxycycline For Rheumatoid Arthritis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 1994 - 1998Specialized Center Of Research In Rheumatoid Arthritis
ResearchCo-Principal Investigator · Awarded by National Institutes of Health · 1987 - 1997External Relationships
- Aditum Bio
- Candid Therapeutics
- Celexor Bio
- Cullinan Therapeutics
- Everest Clinical Research Corporation
- Horizon Therapeutics (purchased Viela Bio) and acquired by Amgen
- Medpace, Inc.
- Moderna Therapeutics, Inc.
- Oblenio
- Related Sciences
- Sonoma Biotherapeutics
- UpToDate, Inc
- immunovant, Inc.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.